Searched for
DRUG PRICING NEGOTIATIONS
US stocks today: US stocks climb as US, Iran halt attacks; Comcast surges on spin-off planWall Street's indices surged on Monday, lifted by a decrease in Middle East tensions and Comcast’s intention to divide into two separate fi...- Trade disruptions, API dependence, compliance costs: Pharma MSMEs spell out policy priorities on World MSME DayIndian pharmaceutical MSMEs are facing immense pressure from rising costs, supply chain woes, and stringent regulations. Industry represent...
- Indian pharma firms gear up to supply key cancer drug to USIndian drugmakers are stepping up to help the US combat a critical shortage of ifosfamide injection, a vital chemotherapy drug. Leading com...
- School assembly news headlines for June 16: Top national, international, business, sports update and thought of the dayIndia and Slovakia elevate ties to a comprehensive partnership. A rival tutor accuses Khan Sir of murder. Delhi census Phase 1 records over...
- Ahead of Market: 10 things that will decide stock market action on MondayMarkets rallied sharply as easing US–Iran tensions and softer crude prices boosted sentiment. Sensex and Nifty surged 2%, adding Rs 10 lakh...
- Stock picks of the week; 5 stocks with consistent score improvement and upside potential of up to 25%Even in normal times it is futile to try and guess the outcome of most global events. But in the New World Order, it makes no sense at all ...
- Global Markets: European stocks rise as STMicroelectronics' forecasts lift tech stocksEuropean shares climbed Tuesday, led by technology stocks boosted by strong forecasts from STMicroelectronics amid AI demand. Investors awa...
- Donald Trump says 'good chance' of Iran nuclear deal after delaying strikeUS President Donald Trump said there was a “very good chance” Washington and Iran could reach a deal to stop Tehran from developing a nucle...
- Hospitals warn Central Government Health Scheme reimbursement cap may hurt cancer treatmentA major private hospital group warns of a crisis for advanced cancer patients under the Central Government Health Scheme. A reimbursement c...
- Donald Trump's drugmaker deals may save economy $529 billion over 10 years: White HousePresident Trump's administration projects significant savings from deals with drug companies. These agreements aim to lower US prescription...
- UK's FTSE 100 slips as losses in energy stocks and AstraZeneca weighLondon’s FTSE 100 edged lower as losses in energy majors and AstraZeneca weighed on the index amid thin holiday trading. Weak crude prices ...
- India supplies 20% of global generic medicines; its IP rules WTO-compliant: GTRIIndia is a major global supplier of affordable generic medicines. The United States continues to pressure India regarding intellectual prop...
- Compliance squeeze, global scrutiny redefine India’s $30 billion pharma export playbookAs global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.
- US stocks today: US market ends higher, S&P 500, Nasdaq notch biggest monthly gains in yearsU.S. stocks surged on Thursday, with the S&P 500 and Nasdaq achieving their largest monthly gains in years. Strong corporate earnings, part...
- Trump pushes pharma tariffs, but exemptions limit impactThe United States has introduced tariffs on branded drug imports. However, many exemptions will limit their effect. Companies investing in ...
- What is Trump's ‘most favored nation’ drug pricing policy and how will it reduce costs? ExplainedPresident Donald Trump on Sunday announced that he will be signing an executive order to reduce prescription drug prices in the US. The 78-...
- Could a new policy change the way Americans pay for drugs forever? Trump's new plan revealedThe Trump administration is exploring a policy to link US drug prices to those of other developed nations. This move is causing concern in ...
- Pharma companies expected to absorb any tariff hit in short termU.S. tariffs on pharmaceuticals are unlikely to immediately raise brand-name drug prices, as drugmakers are expected to absorb initial cost...
- White House says deals struck to cut prices of popular Medicare drugs that cost $50 billion yearlyThe Biden administration announced agreements with drug companies to lower the cost of 10 major Medicare medications, potentially saving ta...
- Patented MNC drugs to face price negotiationsMultinational drugmakers may find this a raw deal from the Prime minister’s Office (PMO).
Load More
